-
2
-
-
0037131385
-
Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved
-
Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A: Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 2002;277:39684-39695.
-
(2002)
J Biol Chem
, vol.277
, pp. 39684-39695
-
-
Pandini, G.1
Frasca, F.2
Mineo, R.3
Sciacca, L.4
Vigneri, R.5
Belfiore, A.6
-
3
-
-
0035115801
-
The somatomedin hypothesis: 2001
-
Le Roith D, Bondy C, Yakar S, Liu JL, Butler A: The somatomedin hypothesis: 2001. Endocr Rev 2001;22:53-74.
-
(2001)
Endocr Rev
, vol.22
, pp. 53-74
-
-
Le Roith, D.1
Bondy, C.2
Yakar, S.3
Liu, J.L.4
Butler, A.5
-
4
-
-
0033305597
-
The essential role of IGF-I: Lessons from the long-term study and treatment of children and adults with Laron syndrome
-
Laron Z: The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome. J Clin Endocrinol Metab 1999;84:4397-4404.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 4397-4404
-
-
Laron, Z.1
-
5
-
-
1642328411
-
Toward a molecular basis for idiopathic short stature
-
Rosenfeld RG, Hwa V: Toward a molecular basis for idiopathic short stature. J Clin Endocrinol Metab 2004;89:1066-1067.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 1066-1067
-
-
Rosenfeld, R.G.1
Hwa, V.2
-
6
-
-
0035175162
-
Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth
-
Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A: Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 2001;229:141-162.
-
(2001)
Dev Biol
, vol.229
, pp. 141-162
-
-
Lupu, F.1
Terwilliger, J.D.2
Lee, K.3
Segre, G.V.4
Efstratiadis, A.5
-
7
-
-
12244280783
-
Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men
-
Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, Willett WC: Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 2003;12:84-89.
-
(2003)
Cancer Epidemiol Biomarkers Prev
, vol.12
, pp. 84-89
-
-
Giovannucci, E.1
Pollak, M.2
Liu, Y.3
Platz, E.A.4
Majeed, N.5
Rimm, E.B.6
Willett, W.C.7
-
8
-
-
0042173160
-
Serum insulin-like growth factor I: Tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men
-
Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D: Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men. Cancer Res 2003;63:3991-3994.
-
(2003)
Cancer Res
, vol.63
, pp. 3991-3994
-
-
Woodson, K.1
Tangrea, J.A.2
Pollak, M.3
Copeland, T.D.4
Taylor, P.R.5
Virtamo, J.6
Albanes, D.7
-
9
-
-
0035743238
-
Determination of insulin-like growth factor I in children: Normal values and clinical use
-
Juul A: Determination of insulin-like growth factor I in children: normal values and clinical use. Horm Res 2001;55(suppl 2):94-99.
-
(2001)
Horm Res
, vol.55
, Issue.2 SUPPL.
, pp. 94-99
-
-
Juul, A.1
-
10
-
-
0030656605
-
Pioneering recombinant growth hormone manufacturing: Pounds produced per mile of height
-
Cronin MJ: Pioneering recombinant growth hormone manufacturing: pounds produced per mile of height. J Pediatr 1997;131:S5-S7.
-
(1997)
J Pediatr
, vol.131
-
-
Cronin, M.J.1
-
11
-
-
0035012283
-
Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the Growth Hormone Research Society
-
Growth Hormone Research Society: Critical evaluation of the safety of recombinant human growth hormone administration: Statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 2001;86:1868-1870.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 1868-1870
-
-
-
12
-
-
0031846497
-
Effect of long-term recombinant growth hormone therapy in children - The National Cooperative Growth Study, USA, 1985-1994
-
Root AW, Kemp SF, Rundle AC, Dana K, Attie KM: Effect of long-term recombinant growth hormone therapy in children - the National Cooperative Growth Study, USA, 1985-1994. J Pediatr Endocrinol Metab 1998;11:403-412.
-
(1998)
J Pediatr Endocrinol Metab
, vol.11
, pp. 403-412
-
-
Root, A.W.1
Kemp, S.F.2
Rundle, A.C.3
Dana, K.4
Attie, K.M.5
-
13
-
-
0035742586
-
Safety in growth hormone replacement therapy: A matter of varied responsiveness?
-
200
-
Wilton P: Safety in growth hormone replacement therapy: a matter of varied responsiveness? Horm Res 200;55(suppl 2):61-64.
-
Horm Res
, vol.55
, Issue.2 SUPPL.
, pp. 61-64
-
-
Wilton, P.1
-
14
-
-
0036884998
-
LWPES Executive Committee and the LWPES Drug and Therapeutics Committee: Growth hormone treatment and neoplasia - Coincidence or consequence?
-
Sperling MA, Saenger PH, Hintz R, Wilson T, Rose SR; Lawson Wilkins Pediatric Endocrine Society. LWPES Executive Committee and the LWPES Drug and Therapeutics Committee: Growth hormone treatment and neoplasia - coincidence or consequence? J Clin Endocrinol Metab 2002;87:5351-5352.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 5351-5352
-
-
Sperling, M.A.1
Saenger, P.H.2
Hintz, R.3
Wilson, T.4
Rose, S.R.5
-
15
-
-
84921702893
-
FDA approves growth hormone for short children
-
FDA approves growth hormone for short children (editorial). Child Health Alert 2003;21:4.
-
(2003)
Child Health Alert
, vol.21
, pp. 4
-
-
-
16
-
-
0033539018
-
Increased mortality associated with growth hormone treatment in critically ill adults
-
Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999;341:785-792.
-
(1999)
N Engl J Med
, vol.341
, pp. 785-792
-
-
Takala, J.1
Ruokonen, E.2
Webster, N.R.3
Nielsen, M.S.4
Zandstra, D.F.5
Vundelinckx, G.6
Hinds, C.J.7
-
17
-
-
0035829852
-
Intensive insulin therapy in the critically ill patients
-
van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-1367.
-
(2001)
N Engl J Med
, vol.345
, pp. 1359-1367
-
-
Van Den Berghe, G.1
Wouters, P.2
Weekers, F.3
Verwaest, C.4
Bruyninckx, F.5
Schetz, M.6
Vlasselaers, D.7
Ferdinande, P.8
Lauwers, P.9
Bouillon, R.10
-
18
-
-
0030897458
-
Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: A phase II safety and efficacy trial
-
Hatton J, Rapp RP, Kudsk KA, Brown RO, Luer MS, Bukar JG, Chen SA, McClain CJ, Gesundheit N, Dempsey RJ, Young B: Intravenous insulin-like growth factor-I (IGF-I) in moderate-to-severe head injury: A phase II safety and efficacy trial. J Neurosurg 1997;86:779-786.
-
(1997)
J Neurosurg
, vol.86
, pp. 779-786
-
-
Hatton, J.1
Rapp, R.P.2
Kudsk, K.A.3
Brown, R.O.4
Luer, M.S.5
Bukar, J.G.6
Chen, S.A.7
McClain, C.J.8
Gesundheit, N.9
Dempsey, R.J.10
Young, B.11
-
19
-
-
0025333249
-
Premature mortality due to cardiovascular disease in hypopituitarism
-
Rosen T, Bengtsson BA: Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990;336:285-288.
-
(1990)
Lancet
, vol.336
, pp. 285-288
-
-
Rosen, T.1
Bengtsson, B.A.2
-
20
-
-
0346095213
-
Acromegaly and colorectal cancer: A comprehensive review of epidemiology, biological mechanisms, and clinical implications
-
Renehan AG, O'Connell J, O'Halloran D, Shanahan F, Potten CS, O'Dwyer ST, Shalet SM: Acromegaly and colorectal cancer: A comprehensive review of epidemiology, biological mechanisms, and clinical implications. Horm Metab Res 2003;35:712-725.
-
(2003)
Horm Metab Res
, vol.35
, pp. 712-725
-
-
Renehan, A.G.1
O'Connell, J.2
O'Halloran, D.3
Shanahan, F.4
Potten, C.S.5
O'Dwyer, S.T.6
Shalet, S.M.7
-
21
-
-
0031759850
-
Mortality and cancer incidence in acromegaly: A retrospective cohort study
-
United Kingdom Acromegaly Study Group
-
Orme SM, McNally RJ, Cartwright RA, Belchetz PE: Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998;83:2730-2734.
-
(1998)
J Clin Endocrinol Metab
, vol.83
, pp. 2730-2734
-
-
Orme, S.M.1
McNally, R.J.2
Cartwright, R.A.3
Belchetz, P.E.4
-
22
-
-
0035404392
-
Acromegaly and cancer: Not a problem?
-
Melmed S: Acromegaly and cancer: not a problem? J Clin Endocrinol Metab 2001;86:2929-2934.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 2929-2934
-
-
Melmed, S.1
-
23
-
-
0034928043
-
Clinical perspective: Acromegaly and cancer: A problem
-
Jenkins PJ, Besser M: Clinical perspective: acromegaly and cancer: A problem. J Clin Endocrinol Metab 2001;86:2935-2941.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 2935-2941
-
-
Jenkins, P.J.1
Besser, M.2
-
24
-
-
0346732359
-
Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders
-
Mukherjee A, Monson JP, Jonsson PJ, Trainer PJ, Shalet SM; KIMS International Board: Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. J Clin Endocrinol Metab 2003;88:5865-5870.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 5865-5870
-
-
Mukherjee, A.1
Monson, J.P.2
Jonsson, P.J.3
Trainer, P.J.4
Shalet, S.M.5
-
25
-
-
0346725867
-
Nutrition, insulin, insulin-like growth factors and cancer
-
Giovannucci E: Nutrition, insulin, insulin-like growth factors and cancer. Horm Metab Res 2003;35:694-704.
-
(2003)
Horm Metab Res
, vol.35
, pp. 694-704
-
-
Giovannucci, E.1
-
26
-
-
0031454715
-
Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice
-
Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J: Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 1997;100:2744-2751.
-
(1997)
J Clin Invest
, vol.100
, pp. 2744-2751
-
-
Wennbo, H.1
Gebre-Medhin, M.2
Gritli-Linde, A.3
Ohlsson, C.4
Isaksson, O.G.5
Tornell, J.6
-
27
-
-
0037340052
-
Local insulin-like growth factor-II mediates prolactin-induced mammary gland development
-
Hovey RC, Harris J, Hadsell DL, Lee AV, Ormandy CJ, Vonderhaar BK: Local insulin-like growth factor-II mediates prolactin-induced mammary gland development. Mol Endocrinol 2003;17:460-471.
-
(2003)
Mol Endocrinol
, vol.17
, pp. 460-471
-
-
Hovey, R.C.1
Harris, J.2
Hadsell, D.L.3
Lee, A.V.4
Ormandy, C.J.5
Vonderhaar, B.K.6
-
28
-
-
0032079677
-
Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice
-
Pravtcheva DD, Wise TL: Metastasizing mammary carcinomas in H19 enhancers-Igf2 transgenic mice. J Exp Zool 1998;281:43-57.
-
(1998)
J Exp Zool
, vol.281
, pp. 43-57
-
-
Pravtcheva, D.D.1
Wise, T.L.2
-
29
-
-
0037434663
-
Transgenic overexpression of IGF-II induces spontaneous lung tumors: A model for human lung adenocarcinoma
-
Moorehead RA, Sanchez OH, Baldwin RM, Khokha R: Transgenic overexpression of IGF-II induces spontaneous lung tumors: A model for human lung adenocarcinoma. Oncogene 2003;22:853-857.
-
(2003)
Oncogene
, vol.22
, pp. 853-857
-
-
Moorehead, R.A.1
Sanchez, O.H.2
Baldwin, R.M.3
Khokha, R.4
-
30
-
-
0031053537
-
Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice
-
Chen NY, Chen WY, Striker LJ, Striker GE, Kopchick JJ: Co-expression of bovine growth hormone (GH) and human GH antagonist genes in transgenic mice. Endocrinology 1997;138:851-854.
-
(1997)
Endocrinology
, vol.138
, pp. 851-854
-
-
Chen, N.Y.1
Chen, W.Y.2
Striker, L.J.3
Striker, G.E.4
Kopchick, J.J.5
-
31
-
-
0023945744
-
Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1
-
Doi T, Striker LJ, Quaife C, Conti FG, Palmiter R, Behringer R, Brinster R, Striker GE: Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. Am J Pathol 1988;131:398-403.
-
(1988)
Am J Pathol
, vol.131
, pp. 398-403
-
-
Doi, T.1
Striker, L.J.2
Quaife, C.3
Conti, F.G.4
Palmiter, R.5
Behringer, R.6
Brinster, R.7
Striker, G.E.8
-
32
-
-
0029923352
-
The obese growth hormone (GH)-deficient dwarf rat: Body fat responses to patterned delivery of GH and insulin-like growth factor-I
-
Clark RG, Mortensen DL, Carlsson LM, Carlsson B, Carmignac D, Robinson IC: The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I. Endocrinology 1996;137:1904-1912.
-
(1996)
Endocrinology
, vol.137
, pp. 1904-1912
-
-
Clark, R.G.1
Mortensen, D.L.2
Carlsson, L.M.3
Carlsson, B.4
Carmignac, D.5
Robinson, I.C.6
-
33
-
-
0035033682
-
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity
-
Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D: Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001;50:1110-1118.
-
(2001)
Diabetes
, vol.50
, pp. 1110-1118
-
-
Yakar, S.1
Liu, J.L.2
Fernandez, A.M.3
Wu, Y.4
Schally, A.V.5
Frystyk, J.6
Chernausek, S.D.7
Mejia, W.8
Le Roith, D.9
-
34
-
-
0141755327
-
Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: Relative roles of growth hormone and IGF-1 in insulin resistance
-
Haluzik M, Yakar S, Gavrilova O, Setser J, Boisclair Y, LeRoith D: Insulin resistance in the liver-specific IGF-1 gene-deleted mouse is abrogated by deletion of the acid-labile subunit of the IGF-binding protein-3 complex: relative roles of growth hormone and IGF-1 in insulin resistance. Diabetes 2003;52:2483-2489.
-
(2003)
Diabetes
, vol.52
, pp. 2483-2489
-
-
Haluzik, M.1
Yakar, S.2
Gavrilova, O.3
Setser, J.4
Boisclair, Y.5
LeRoith, D.6
-
35
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
-
(1993)
N Engl J Med
, vol.329
, pp. 977-986
-
-
-
36
-
-
0033035850
-
Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes
-
RhIGF-I in IDDM Study Group
-
Thrailkill KM, Quattrin T, Baker L, Kuntze JE, Compton PG, Martha PM Jr: Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group. Diabetes Care 1999;22:585-592.
-
(1999)
Diabetes Care
, vol.22
, pp. 585-592
-
-
Thrailkill, K.M.1
Quattrin, T.2
Baker, L.3
Kuntze, J.E.4
Compton, P.G.5
Martha Jr., P.M.6
-
37
-
-
11144354304
-
Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease
-
Ruberte J, Ayuso E, Navarro M, Carretero A, Nacher V, Haurigot V, George M, Llombart C, Casellas A, Costa C, Bosch A, Bosch F: Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J Clin Invest 2004;113:1149-1157.
-
(2004)
J Clin Invest
, vol.113
, pp. 1149-1157
-
-
Ruberte, J.1
Ayuso, E.2
Navarro, M.3
Carretero, A.4
Nacher, V.5
Haurigot, V.6
George, M.7
Llombart, C.8
Casellas, A.9
Costa, C.10
Bosch, A.11
Bosch, F.12
-
38
-
-
0041743158
-
Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization
-
Kondo T, Vicent D, Suzuma K, Yanagisawa M, King GL, Holzenberger M, Kahn CR: Knockout of insulin and IGF-1 receptors on vascular endothelial cells protects against retinal neovascularization. J Clin Invest 2003;111:1835-1842.
-
(2003)
J Clin Invest
, vol.111
, pp. 1835-1842
-
-
Kondo, T.1
Vicent, D.2
Suzuma, K.3
Yanagisawa, M.4
King, G.L.5
Holzenberger, M.6
Kahn, C.R.7
-
39
-
-
0037143639
-
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: A population-based case-control study
-
Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T: Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: A population-based case-control study. Circulation 2002;106:939-944.
-
(2002)
Circulation
, vol.106
, pp. 939-944
-
-
Juul, A.1
Scheike, T.2
Davidsen, M.3
Gyllenborg, J.4
Jorgensen, T.5
-
40
-
-
0037143636
-
Cardiovascular disease and insulin-like growth factor I
-
Frystyk J, Ledet T, Moller N, Flyvbjerg A, Orskov H: Cardiovascular disease and insulin-like growth factor I. Circulation 2002;106:893-895.
-
(2002)
Circulation
, vol.106
, pp. 893-895
-
-
Frystyk, J.1
Ledet, T.2
Moller, N.3
Flyvbjerg, A.4
Orskov, H.5
-
41
-
-
0035126968
-
A polymorphism in the gene for IGF-I: Functional properties and risk for type 2 diabetes and myocardial infarction
-
Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM: A polymorphism in the gene for IGF-I: Functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-642.
-
(2001)
Diabetes
, vol.50
, pp. 637-642
-
-
Vaessen, N.1
Heutink, P.2
Janssen, J.A.3
Witteman, J.C.4
Testers, L.5
Hofman, A.6
Lamberts, S.W.7
Oostra, B.A.8
Pols, H.A.9
Van Duijn, C.M.10
-
42
-
-
0842291511
-
The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study
-
Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D: The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: The Rancho Bernardo Study. J Clin Endocrinol Metab 2004;89:114-120.
-
(2004)
J Clin Endocrinol Metab
, vol.89
, pp. 114-120
-
-
Laughlin, G.A.1
Barrett-Connor, E.2
Criqui, M.H.3
Kritz-Silverstein, D.4
-
43
-
-
0142056143
-
Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: The Framingham Heart Study
-
Vasan RS, Sullivan LM, D'Agostino RB, Roubenoff R, Harris T, Sawyer DB, Levy D, Wilson PW: Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 2003;139:642-648.
-
(2003)
Ann Intern Med
, vol.139
, pp. 642-648
-
-
Vasan, R.S.1
Sullivan, L.M.2
D'Agostino, R.B.3
Roubenoff, R.4
Harris, T.5
Sawyer, D.B.6
Levy, D.7
Wilson, P.W.8
-
44
-
-
0141892842
-
Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study
-
Roubenoff R, Parise H, Payette HA, Abad LW, D'Agostino R, Jacques PF, Wilson PW, Dinarello CA, Harris TB: Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: The Framingham Heart Study. Am J Med 2003;115:429-435.
-
(2003)
Am J Med
, vol.115
, pp. 429-435
-
-
Roubenoff, R.1
Parise, H.2
Payette, H.A.3
Abad, L.W.4
D'Agostino, R.5
Jacques, P.F.6
Wilson, P.W.7
Dinarello, C.A.8
Harris, T.B.9
-
45
-
-
0042884446
-
Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: The Rotterdam Study
-
Rivadeneira F, Houwing-Duistermaat JJ, Vaessen N, Vergeer-Drop JM, Hofman A, Pols HA, Van Duijn CM, Uitterlinden AG: Association between an insulin-like growth factor I gene promoter polymorphism and bone mineral density in the elderly: The Rotterdam Study. J Clin Endocrinol Metab 2003;88:3878-3884.
-
(2003)
J Clin Endocrinol Metab
, vol.88
, pp. 3878-3884
-
-
Rivadeneira, F.1
Houwing-Duistermaat, J.J.2
Vaessen, N.3
Vergeer-Drop, J.M.4
Hofman, A.5
Pols, H.A.6
Van Duijn, C.M.7
Uitterlinden, A.G.8
-
46
-
-
0036917631
-
Serum insulin-like growth factor I regulates brain amyloid-beta levels
-
Carro E, Trejo JL, Gomez-Isla T, LeRoith D, Torres-Aleman I: Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat Med 2002;8:1390-1397.
-
(2002)
Nat Med
, vol.8
, pp. 1390-1397
-
-
Carro, E.1
Trejo, J.L.2
Gomez-Isla, T.3
LeRoith, D.4
Torres-Aleman, I.5
-
47
-
-
0034489209
-
A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly
-
Kalmijn S, Janssen JA, Pols HA, Lamberts SW, Breteler MM: A prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderly. J Clin Endocrinol Metab 2000;85:4551-4555.
-
(2000)
J Clin Endocrinol Metab
, vol.85
, pp. 4551-4555
-
-
Kalmijn, S.1
Janssen, J.A.2
Pols, H.A.3
Lamberts, S.W.4
Breteler, M.M.5
-
48
-
-
0037411496
-
Insulin-like growth factor I (IGF-I) and cognitive decline in older persons
-
Dik MG, Pluijm SM, Jonker C, Deeg DJ, Lomecky MZ, Lips P: Insulin-like growth factor I (IGF-I) and cognitive decline in older persons. Neurobiol Aging 2003;24:573-581.
-
(2003)
Neurobiol Aging
, vol.24
, pp. 573-581
-
-
Dik, M.G.1
Pluijm, S.M.2
Jonker, C.3
Deeg, D.J.4
Lomecky, M.Z.5
Lips, P.6
-
49
-
-
0036827566
-
Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice
-
Tivesten A, Bollano E, Andersson I, Fitzgerald S, Caidahl K, Sjogren K, Skott O, Liu JL, Mobini R, Isaksson OG, Jansson JO, Ohlsson C, Bergstrom G, Isgaard J: Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 2002;143:4235-4242.
-
(2002)
Endocrinology
, vol.143
, pp. 4235-4242
-
-
Tivesten, A.1
Bollano, E.2
Andersson, I.3
Fitzgerald, S.4
Caidahl, K.5
Sjogren, K.6
Skott, O.7
Liu, J.L.8
Mobini, R.9
Isaksson, O.G.10
Jansson, J.O.11
Ohlsson, C.12
Bergstrom, G.13
Isgaard, J.14
-
50
-
-
0034877472
-
IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming
-
Vickers MH, Ikenasio BA, Breier BH: IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming. Endocrinology 2001;142:3964-3973.
-
(2001)
Endocrinology
, vol.142
, pp. 3964-3973
-
-
Vickers, M.H.1
Ikenasio, B.A.2
Breier, B.H.3
-
51
-
-
12944335316
-
Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice
-
DiGiovanni J, Kiguchi K, Frijhoff A, Wilker E, Bol DK, Beltran L, Moats S, Ramirez A, Jorcano J, Conti C: Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc Natl Acad Sci USA 2000;97:345 5-3460.
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 3455-3460
-
-
DiGiovanni, J.1
Kiguchi, K.2
Frijhoff, A.3
Wilker, E.4
Bol, D.K.5
Beltran, L.6
Moats, S.7
Ramirez, A.8
Jorcano, J.9
Conti, C.10
-
52
-
-
0036031802
-
Novel activities of pro-IGF-I E peptides: Regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells
-
Kuo YH, Chen TT: Novel activities of pro-IGF-I E peptides: regulation of morphological differentiation and anchorage-independent growth in human neuroblastoma cells. Exp Cell Res 2002;280:75-89.
-
(2002)
Exp Cell Res
, vol.280
, pp. 75-89
-
-
Kuo, Y.H.1
Chen, T.T.2
-
53
-
-
17244380362
-
Lifetime (104 Week) daily subcutaneous rhIGF-I treatment in the rat
-
Philadelphia, June
-
Dybdal N, Elwell M, Christian B, Clark R, Fielder P, Kennedy D, Shopp D, Thakur A, Clarke J: Lifetime (104 Week) daily subcutaneous rhIGF-I treatment in the rat (abstract). 85th Annual Meeting of the Endocrine Society, Philadelphia, June 2003, 3-318.
-
(2003)
85th Annual Meeting of the Endocrine Society
, pp. 3-318
-
-
Dybdal, N.1
Elwell, M.2
Christian, B.3
Clark, R.4
Fielder, P.5
Kennedy, D.6
Shopp, D.7
Thakur, A.8
Clarke, J.9
-
54
-
-
17244369332
-
-
NovoLog product label. Available at http:// www.fda.gov/cder/foi/label/ 2000/209861bl.pdf. Accessed April 23, 2004.
-
-
-
-
55
-
-
0042092531
-
Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans
-
Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Allonger J, Li H, Kenyon C: Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 2003;424:277-283.
-
(2003)
Nature
, vol.424
, pp. 277-283
-
-
Murphy, C.T.1
McCarroll, S.A.2
Bargmann, C.I.3
Fraser, A.4
Kamath, R.S.5
Allonger, J.6
Li, H.7
Kenyon, C.8
|